Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has informed that pursuant to Regulation 30(5) of the Securities And Exchange Board of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, Dilip Shanghvi, Managing Director, Sudhir V. Valia, Whole Time Director, Sailesh Desai Whole Time Director, Uday Baldota, CFO and Sunil Ajmera, Company Secretary have been authorized severally to determine materiality of an event or information and for making disclosures to Stock Exchange(s).

The above information is a part of company’s filings submitted to BSE.